# Suzhou Zhongke Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-zhongke-biotechnology

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Series A (Mar 9, 2026)
- Investors on record: 1

## About

Founded in 2016 and based in Hangzhou, China, Suzhou Zhongke Biomedical Materials Co., Ltd., dba Suzhou Zhongke Biotechnology, operates as a biomedical materials and orthopedic implant R&D company. The company focuses on the development of high-performance, high-biocompatibility orthopedic prosthetic materials and devices designed to meet the clinical needs of orthopedic surgery. In March 2026, Suzhou Zhongke Biotechnology raised Series A funding from Ruijie Medical Management and LH Ventures.
The company is engaged in the research, development, and commercialization of orthopedic prostheses, including implantable medical devices and related biomedical materials. Its activities span medical materials R&D, orthopedic implant design, and technology services, with a focus on improving clinical performance and patient outcomes.
The company’s revenue is primarily derived from the development and future commercialization of orthopedic implants and biomedical materials, as well as technical services related to medical device research and development.

## Funding rounds

- Series A, Mar 9, 2026 — LH Ventures

## Investors

- LH Ventures (https://capitalatlas.ai/funds/lh-ventures) — Series A